Quality of care indicators related to premature readmission and death after hospitalization for heart failure;Indicadores de calidad relacionados con el reingreso y la muerte precoces tras la hospitalización por insuficiencia cardíaca

Medicina Clinica

Volumn 126, Issue 5, 2006, Pages 165-169

  Trujillo Santos, A Javier ^a,b   Domingo González, Soraya ^a   Gonzalo Blanquer, Jerónimo ^a   Perea Milla, Emilio ^a   Jiménez Puente, Alberto ^a   García Alegría, Javier ^a  

^a HOSPITAL COSTA DEL SOL   (Spain)

^b Allergy Section   (Spain)

Author keywords

Congestive heart failure; Quality of care; Readmissions

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METOPROLOL; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; COMORBIDITY; CONGESTIVE HEART FAILURE; DEATH; DISEASE SEVERITY; FEMALE; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEART FAILURE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE;

EID: 33645090680     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13084534     Document Type: Article

References (24)

1. Sharpe N. HF Management principles: much more to be gained. En: Sharpe N, editor. Heart failure management. London: Martin Dunitz; 2000.
2. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham Study. N Engl J Med. 1987; 285:1441-6.
3. Rodríguez-Artalejo F, Guallar-Castillón P, Banegas JR, Del Rey Calero J. Trends in hospitalization and mortality for heart failure in Spain, 1980-1993. Eur Heart J. 1997;18:1771-9.
4. Jessup M, Brozena S. Heart failure. N Engl J Med. 2003;348:2007-18.
5. Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, Sutton GC. The epidemiology of heart failure. Eur Heart J. 1997;18:208-23.
6. Benbassat J, Taragin M. Hospital readmissions as a measure of quality of health care: advantages and limitations. Arch Intern Med. 2000; 160:1074-81.
7. Thomas JW, Holloway JJ. Investigating early readmission as an indicator for quality of care studies. Med Care. 1991;29:377-94.
8. García-Alegría J, Martín-Escalante MD, Hidalgo-Rojas L. Aspectos organizativos y calidad de atención en la insuficiencia cardíaca. Rev Clin Esp. 2001;201 Supl 1:7-15.
9. Krumholz HM, Parent EM, Tu N, Vaccarino V, Wang Y, Radford MJ, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med. 1997; 157:99-104.
10. Konstam MA. Progress in heart failure management? Lessons from the real world. Circulation. 2000;102:1076-8.
11. Hadorn DC, Baker DW, Kamberg CJ, Brooks RH. Phase II of the AHCPR-sponsored heart failure guideline: translating practice recommendations into review criterion. Jt Comm J Qual Improv. 1996;22:265.
12. Joint Commission's Disease-Specific Heart Failure Expert Panel. Joint Commission's Disease-Specific Care Standardized Heart Failure Measure Set [accedido 1 Sep 2003]. Disponible en: http://www.jcaho.org/dscc/ performance+measures/heart+failure+measure+set.htm
13. Krumholz HM, Baker DW, Ashton CM, Dunbar SB, Friesinger GC, Havranek EP, et al. Evaluating quality of care for patients with heart failure. Circulation. 2000;101:e122-e40.
14. Fonarow GC. Quality indicators for the management of heart failure in vulnerable elders. Ann Intern Med. 2001;13:694-702.
15. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet. 1993;342: 1317-22.
16. Packer M, Fowler MB, Roecker EB, Coats AJ, Katus HA, Krum H, et al. Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Circulation. 2002;106:2194-9.
17. Shibata MC, Flather MD, Wang D. Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure. Eur Heart J. 2001;3:351-7.
18. Pitt B, Zannad F, Remme W, Cody R, Castaigne A, Pérez A, et al. Randomized Aldactone Evaluation Study (RALES) Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341:709-17.
19. Librero J, Peiró S, Ordiñana R. Chronic comorbidity and outcomes of hospital care: length of stay, mortality and readmissions at 30 and 365 days. J Clin Epidemiol. 1999;52:171-9.
20. Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G, et al. Long-term ACE-inhibitor therapy in patients with heart failure on left-ventricular dysfunction: a systematic overview of data from individual patients. Lancet. 2000;355:1575-81.
21. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Eng J Med. 1997;336:525-33.
22. Konstam MA. Relating quality of care to clinical outcomes in heart failure. J Card Fail. 2001;7: 299-301.
23. Hofer TP, Hayward RA. Can early readmission rates accurately detect poor-quality hospitals? Med Care. 1995;33:234-45.
24. Ashton CM, Del Junco DJ, Souchek S, Wray NP, Mansyur CL. The association between quality of inpatient care and early readmission: a metaanalysis of the evidence. Med Care. 1997;35: 1044-59.